Italia markets closed

Sarepta Therapeutics, Inc. (0L35.L)

LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
143,89-4,20 (-2,84%)
Alla chiusura: 06:40PM BST

Elenco insider

Individuo o enteUltima transazioneDataAzioni possedute alla data della transazione

ARIF BILAL
Chief Technology Officer

Sale

25 giu 2024

17.363

BARRY RICHARD J
Director

Stock Award(Grant)

01 mar 2024

3.181.690

BEHRENS M KATHLEEN
Director

Conversion of Exercise of derivative security

03 lug 2024

201.839

BOOR KATHRYN JEAN
Director

Sale

11 mar 2024

7.516

BROWN RYAN EDWARD
General Counsel

Sale

25 giu 2024

17.129

ESTEPAN IAN MICHAEL
Chief Financial Officer

Conversion of Exercise of derivative security

21 giu 2024

39.931

MAYO STEPHEN L.
Director

Sale

05 mar 2024

6.621

MURRAY DALLAN
Officer

Conversion of Exercise of derivative security

21 giu 2024

22.023

RODINO-KLAPAC LOUISE
Officer

Conversion of Exercise of derivative security

21 giu 2024

72.141

WIGZELL HANS LENNART RUDOLF
Director

Sale

08 mar 2024

22.840

*I dati sull'elenco interno provengono esclusivamente dai rapporti presentati alla SEC del modulo 3 e 4 degli ultimi 24 mesi.